High Stress Hyperglycemia Ratio Versus Absolute Hyperglycemia as a Predictor of Poor Outcome Among Patients With Type 2 Diabetes Mellitus and Moderate to Critical Covid-19 Infection Admitted at a Tertiary Hospital from 2020-21: A Retrospective Study

Abstract

Background: Patients with diabetes are vulnerable and highly susceptible to contracting COVID-19. Stress hyperglycemia ratio (SHR) may provide prognostic information in hospitalized patients. It is debatable whether stress hyperglycemia directly leads to poor outcomes, or is simply a marker of increased stress and inflammation.

Objective: This study investigates whether high SHR is associated with poor clinical outcomes among patients with type 2 diabetes mellitus (T2DM) and moderate to critical COVID-19 infection. Moreover, this study aims to compare high SHR versus absolute hyperglycemia as a predictor of poor outcomes.

Methodology: A chart review was conducted on 146 COVID-19 patients with T2DM from March 2020 to December 2021. The area under the receiver operating curve was conducted to categorize SHR into low and high levels. The association of high SHR levels and absolute hyperglycemia with outcomes was analyzed using the regression analysis. Survival analysis was also utilized to allow differences in the time when in-hospital mortality occurred.

Result: Patients with high SHR had a significantly higher proportion of mortality and invasive ventilation compared to those with low SHR. High SHR significantly increased the likelihood of invasive ventilation by 16.49 times and mortality hazards by 5.70 times compared to low SHR. Kaplan-Meier survival curves showed that those with high SHR had significantly lower survival rates than those with low SHR. In contrast, the survival estimates between those with and without absolute hyperglycemia were not statistically significant.

Conclusion: High SHR (>1.082) was associated with poorer outcomes, increased invasive mechanical ventilatory support and increased mortality.

Keywords: Stress Hyperglycemia Ratio, Absolute Hyperglycemia, Type 2 Diabetes Mellitus, COVID-19, Poor outcome

  1. Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy [Internet]. 2020;5(1):6. Available from: http://dx.doi.org/10.1186/s41256-020-00135-6

  2. World Health Organization. Philippines: WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization. Available from: https://covid19.who.int/region/wpro/country/ph

  3. Mahase E. Covid-19: What do we know about “long covid”? BMJ [Internet]. 2020;370:m2815. Available from: http://dx.doi.org/10.1136/bmj.m2815 

  4. Kelada M, Anto A, Dave K, Saleh SN. The role of sex in the risk of mortality from COVID-19 amongst adult patients: A systematic review. Cureus [Internet]. 2020;12(8):e10114. Available from: http://dx.doi.org/10.7759/cureus.10114

  5. Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care [Internet]. 2020;24(1):422. Available from: http://dx.doi.org/10.1186/s13054-020-03120-0 

  6. Corrao S, Pinelli K, Vacca M, Raspanti M, Argano C. Type 2 diabetes mellitus and COVID-19: A narrative review. Front Endocrinol (Lausanne) [Internet]. 2021;12:609470. Available from: http://dx.doi.org/10.3389/fendo.2021.609470 

  7. Dungan KM, Braithwaite SS, Preiser J-C. Stress hyperglycaemia. Lancet [Internet]. 2009;373(9677):1798–807. Available from: http://dx.doi.org/10.1016/s0140-6736(09)60553-5 

  8. Davis G, Fayfman M, Reyes-Umpierrez D, Hafeez S, Pasquel FJ, Vellanki P, et al. Stress hyperglycemia in general surgery: Why should we care? J Diabetes Complications [Internet]. 2018;32(3):305–9. Available from: http://dx.doi.org/10.1016/j.jdiacomp.2017.11.010 

  9. Xu W, Song Q, Wang X, Zhao Z, Meng X, Xia C, et al. Association of stress hyperglycemia ratio and in-hospital mortality in patients with coronary artery disease: insights from a large cohort study. Cardiovasc Diabetol [Internet]. 2022;21(1):217. Available from: http://dx.doi.org/10.1186/s12933-022-01645-y 

  10. Wei Q-C, Chen Y-W, Gao Q-Y, Ren K-D, Liu Y-B, He F, et al. Association of stress hyperglycemia with clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a cohort study. Cardiovasc Diabetol [Internet]. 2023;22(1):85. Available from: http://dx.doi.org/10.1186/s12933-023-01812-9 

  11. Yang Y, Kim T-H, Yoon K-H, Chung WS, Ahn Y, Jeong M-H, et al. The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention. Int J Cardiol [Internet]. 2017;241:57–63. Available from: http://dx.doi.org/10.1016/j.ijcard.2017.02.065 

  12. Cariou B, Hadjadj S, Wargny M, Pichelin M, Al-Salameh A, Allix I, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia [Internet]. 2020;63(8):1500–15. Available from: http://dx.doi.org/10.1007/s00125-020-05180-x 

  13. Aon M, Alsaeedi A, Alzafiri A, Al-Shammari A, Taha S, Al-Shammari O, et al. Stress hyperglycemia ratio as a prognostic marker in diabetic patients hospitalized with COVID-19. Infect Dis Rep [Internet]. 2022;14(5):675–85. Available from: http://dx.doi.org/10.3390/idr14050073 

  14. Lazarus G, Audrey J, Wangsaputra VK, Tamara A, Tahapary DL. High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis. Diabetes Res Clin Pract [Internet]. 2021;171(108561):108561. Available from: http://dx.doi.org/10.1016/j.diabres.2020.108561

  15. Yuan C, Chen S, Ruan Y, Liu Y, Cheng H, Zeng Y, et al. The stress hyperglycemia ratio is associated with hemorrhagic transformation in patients with acute ischemic stroke. Clin Interv Aging [Internet]. 2021;16:431–42. Available from: http://dx.doi.org/10.2147/CIA.S280808

  16. DOH 2020. Interim Guidelines on the COVID-19 Disease Severity Classification and Management. Available from: https://doh.gov.ph/sites/default/files/health-update/dm2020-0381.pdf 

  17. American Diabetes Association. Diabetes care in the hospital: standards of medical care in diabetes - 2023.

  18. Luethi N, Cioccari L, Tanaka A, Kar P, Giersch E, Deane AM, et al. Glycated hemoglobin A1c levels are not affected by critical illness. Crit Care Med [Internet]. 2016;44(9):1692–4. Available from: http://dx.doi.org/10.1097/CCM.0000000000001656 

  19. Lee TF, Drake SM, Roberts GW, Bersten A, Stranks SN, Heilbronn LK, et al. Relative hyperglycemia is an independent determinant of in-hospital mortality in patients with critical illness. Crit Care Med [Internet]. 2020;48(2):e115–22. Available from: http://dx.doi.org/10.1097/CCM.0000000000004133 

  20. Roberts GW, Quinn SJ, Valentine N, Alhawassi T, O’Dea H, Stranks SN, et al. Relative hyperglycemia, a marker of critical illness: Introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab [Internet]. 2015;100(12):4490–7. Available from: http://dx.doi.org/10.1210/jc.2015-2660 

  21. Zabuliene L, Kubiliute I, Urbonas M, Jancoriene L, Urboniene J, Ilias I. Hyperglycaemia and its prognostic value in patients with COVID-19 admitted to the hospital in Lithuania. Biomedicines [Internet]. 2023;12(1). Available from: http://dx.doi.org/10.3390/biomedicines12010055 

  22. Marenzi G, Cosentino N, Milazzo V, De Metrio M, Cecere M, Mosca S, et al. Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: A prospective study. Diabetes Care [Internet]. 2018;41(4):847–53. Available from: http://dx.doi.org/10.2337/dc17-1732 

  23. Ramon J, Llauradó G, Güerri R, Climent E, Ballesta S, Benaiges D, et al. Acute-to-chronic glycemic ratio as a predictor of COVID-19 severity and mortality. Diabetes Care [Internet]. 2022;45(1):255–8. Available from: http://dx.doi.org/10.2337/dc21-1321  

  24. Elamari S, Motaib I, Zbiri S, Elaidaoui K, Chadli A, Elkettani C. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Pan Afr Med J [Internet]. 2020;37:32. Available from: http://dx.doi.org/10.11604/pamj.2020.37.32.25192 

  25. Ceriello A. Hyperglycemia and COVID-19: What was known and what is really new? Diabetes Res Clin Pract [Internet]. 2020;167(108383):108383. Available from: http://dx.doi.org/10.1016/j.diabres.2020.108383 

  26. Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, et al. Diabetes mellitus and COVID-19: Review article. Diabetes Metab Syndr [Internet]. 2021;15(6):102268. Available from: http://dx.doi.org/10.1016/j.dsx.2021.102268 

  27. Mahase E. Covid-19: Why are age and obesity risk factors for serious disease? BMJ [Internet]. 2020;371:m4130. Available from: http://dx.doi.org/10.1136/bmj.m4130 

  28. Zhou Y, Ding N, Yang G, Peng W, Tang F, Guo C, et al. Serum lactate dehydrogenase level may predict acute respiratory distress syndrome of patients with fever infected by SARS-CoV-2. Ann Transl Med [Internet]. 2020;8(17):1118. Available from: http://dx.doi.org/10.21037/atm-20-2411

  29. Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int [Internet]. 2020;40(9):2095–103. Available from: http://dx.doi.org/10.1111/liv.14455 

  30. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical Infectious Diseases. 2020. Available from: https://doi.org/10.1093/cid/ciaa270

Articles related to the one you are viewing

There are currently no results to show, please try again later

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.